Excellent long term survival of front-line high-dose chemotherapy with rituximab (HDT) in

被引：0
|
作者：
Dilhuydy, M. [1 ]
Lamy, T. [2 ]
Casassus, P. [3 ]
Deconninck, E. [4 ]
Gressin, R. [5 ]
Le Maignan, C. [6 ]
Milpied, N. [1 ]
机构：
[1] CHU Bordeaux, F-93009 Pessac, France
[2] CHU Rennes, F-25030 Rennes, France
[3] Hop Avicenne, Bobigny, France
[4] CHU Besancon, Hematol & BMT Unit, Besancon, France
[5] Hop Michallon, Grenoble, France
[6] Hop Europeen Georges Pompidou, Paris, France
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：147 / 148
页数：2
相关论文
共 50 条
  • [21] Long-term prognosis for ovarian cancer based on front-line chemotherapy ∼Is it the same for each histological type?
    Kajiyama, Hiroaki
    Shibata, Kiyosumi
    Kikkawa, Fumitaka
    ANNALS OF ONCOLOGY, 2015, 26 : 27 - 27
  • [22] Effect of front-line therapy with either high-dose therapy and autologous stem cell rescue (HDT/ASCR) or dose-intensive therapy (R-Hypercvad) on outcome in mantle cell lymphoma (MCL).
    Feldman, T.
    Mato, A. R.
    Zielonka, T.
    Masood, A.
    Goldberg, S.
    Rowley, S. D.
    Donato, M.
    Siegel, D. S.
    Pecora, A.
    Goy, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] Characteristics associated with long-term progression-free survival following high-dose chemotherapy in metastatic breast cancer and influence of chemotherapy dose
    Schneeweiss, A
    Hensel, M
    Sinn, P
    Khbeis, T
    Haas, R
    Bastert, G
    Ho, AD
    ANNALS OF ONCOLOGY, 2002, 13 (05) : 679 - 688
  • [24] The effect of front-line chemotherapy on overall survival in patients with malignant pleural mesothelioma.
    Elkiran, Emin Tamer
    Sevinc, Alper
    Harputluoglu, Hakan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] THE EFFECT OF FRONT-LINE CHEMOTHERAPY ON OVERALL SURVIVAL IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA.
    Sevinc, Alper
    Elkiran, Emin T.
    Harputluoglu, Hakan
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S639 - S639
  • [26] High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: long-term results
    Carella, Angelo Michele
    Bellei, Monica
    Brice, Pauline
    Gisselbrecht, Christian
    Visani, Giuseppe
    Colombat, Philippe
    Fabbiano, Francesco
    Donelli, Amedea
    Luminari, Stefano
    Feugier, Pierre
    Browett, Peter
    Hagberg, Hans
    Federico, Massimo
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (01): : 146 - 148
  • [27] High-dose therapy and autologous hematopoietic cell transplantation as front-line consolidation in chronic lymphocytic leukemia: a systematic review
    Reljic, T.
    Kumar, A.
    Djulbegovic, B.
    Kharfan-Dabaja, M. A.
    BONE MARROW TRANSPLANTATION, 2015, 50 (08) : 1069 - 1074
  • [28] High-dose radiotherapy in trimodality treatment of Pancoast tumors results in high pathologic complete response rates and excellent long-term survival
    Kwong, KF
    Edelman, MJ
    Suntharalingam, M
    Cooper, LB
    Gamliel, Z
    Burrows, W
    Hausner, P
    Doyle, LA
    Krasna, MJ
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 129 (06): : 1250 - 1257
  • [29] Long Term Survival After High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation in Metastatic Breast Cancer.
    Hamilton, Betty K.
    Bolwell, Brian J.
    Rybicki, Lisa
    Tench, Shawnda
    Kalaycio, Matt
    Andresen, Steven
    Dean, Robert M.
    Sobecks, Ronald
    Pohlman, Brad
    Hill, Brian T.
    Hanna, Rabi
    Duong, Hien K.
    Copelan, Edward A.
    BLOOD, 2012, 120 (21)
  • [30] Long-term survival after high-dose salvage chemotherapy for germ cell malignancies with adverse prognostic variables
    Vaena, DA
    Abonour, R
    Einhorn, LH
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (22) : 4100 - 4104
12345